help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 5, 2005, doi:10.1165/rcmb.2005-0005OC

Am. J. Respir. Cell Mol. Biol., Volume 33, Number 2, August 2005, 138-144

A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0005OCv1
33/2/138    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waters, V.
Right arrow Articles by Prince, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waters, V.
Right arrow Articles by Prince, A.

Submitted on January 5, 2005
Revised on May 5, 2005

The Effect of Cyclosporin A on Airway Cell Pro-Inflammatory Signaling and Pneumonia

Valerie Waters1, Sach Sokol1, Bharat Reddy1, Grace Soong1, Jarin Chun1, and Alice Prince1*

1 Department of Pediatrics and Pharmacology, Columbia University, New York, NY, USA

* To whom correspondence should be addressed. E-mail: asp7{at}columbia.edu.

Cyclosporin A (CsA) blocks T cell activation by interfering with the Ca2+-dependent phosphatase, calciuneurin. Proinflammatory responses to bacteria that are activated by Ca2+-fluxes in the airway are a potential target for CsA. While local immunosuppression may be advantageous to control airway inflammation, it could also increase susceptibility to bacterial pneumonia and invasive infection. As aerosolized CsA is currently under study in lung transplantation, we examined its direct effects on airway cells as well as in a murine model of pneumonia. Epithelial IL-6 production was very effectively inhibited by CsA whereas CXCL8 production, the major PMN chemokine, was only modestly diminished. Responses to a TLR2 agonist Pam3Cys were more sensitive to CsA inhibition than those activated by P. aeruginosa. CsA substantially blocked NFAT and CREB activation (P<0.001), inhibited C/EBP by 50% (P<0.05) and minimally blocked AP-1 and NF-{kappa}B responses to bacteria in epithelial cells. The in vitro effects were confirmed in a mouse model of P. aeruginosa infection with similar rates of PMN recruitment, pneumonia and mortality in CsA treated and control mice. These studies indicate that airway epithelial signaling is a potential target for CsA, and such local immunosuppression may not increase susceptibility to invasive infection.




This article has been cited by other articles:


Home page
CVIHome page
P. Mendez-Samperio, A. Trejo, and A. Perez
Mycobacterium bovis Bacillus Calmette-Guerin Induces CCL5 Secretion via the Toll-Like Receptor 2-NF-{kappa}B and -Jun N-Terminal Kinase Signaling Pathways
Clin. Vaccine Immunol., February 1, 2008; 15(2): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi, and B. J. Petrof
Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-{kappa}B and Calcineurin
Infect. Immun., December 1, 2006; 74(12): 6829 - 6838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.